Functional dyspepsia and gastroparesis: One disease or two

American Journal of Gastroenterology

Volumn 107, Issue 11, 2012, Pages 1615-1620

  Lacy, Brian E ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOMPERIDONE; DULOXETINE; GABAPENTIN; PLACEBO; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; BLOATING; DYSPEPSIA; ENDOSCOPY; EPIGASTRIC DISCOMFORT; EPIGASTRIC FULLNESS; EPIGASTRIC PAIN; GASTROINTESTINAL SYMPTOM; HUMAN; NAUSEA; PALPATION; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; POSTPRANDIAL STATE; PRIORITY JOURNAL; SATIETY; STOMACH; STOMACH PARESIS; VOMITING; WEIGHT REDUCTION;

DYSPEPSIA; GASTRIC EMPTYING; GASTROPARESIS; HUMANS;

EID: 84869386892     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2012.104     Document Type: Article

References (46)

1. El-Serag HB, Talley NJ. Systematic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther 2004;19:643-54. (Pubitemid 38445425)
2. Soykan I, Sivri B, Sarosiek I et al. Demography, clinical characteristics, psychological and abuse profiles, treatment, and long term follow-up of patients with gastroparesis. Dig Dis Sci 1998;43:2398-404. (Pubitemid 28531310)
3. Lacy BE, Koch KL, Crowell MD. The stomach: normal function and clinical disorders. In: Schuster MM, Crowell MD, Koch KL (eds). Schuster Atlas of Gastrointestinal Motility in Health and Disease, 2nd edn. BC Decker: Hamilton, ON, Canada, 2002, pp 135-50.
4. Tack J, Talley NJ, Camilleri M et al. Functional gastroduodenal disorders. Gastroenterology 2006;130:1466-79.
5. Parkman HP, Hasler WL, Fisher RS. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology 2004;127:1592-622. (Pubitemid 39457783)
6. Delgado-Aros S, Camilleri M, Cremonini F et al. Contributions of gastric volumes and gastric emptying to meal size and postmeal symptoms in functional dyspepsia. Gastroenterology 2004;127:1685-94. (Pubitemid 39575847)
7. Karamanolis G, Caenepeel P, Arts J et al. Association of the predominant symptom with clinical characteristics and pathophysiological mechanisms in functional dyspepsia. Gastroenterology 2006;130:296-303. (Pubitemid 43202029)
8. Van Lelyveld N, Schipper M, Samsom M. Lack of relationship between chronic upper abdominal symptoms and gastric function in functional dyspepsia. Dig Dis Sci 2008;53:1223-30. (Pubitemid 351514620)
9. Punkkinen J, Farkkila M, Matzke S et al. Upper abdominal symptoms in patients with Type 1 diabetes: unrelated to impairment in gastric emptying caused by autonomic neuropathy. Diabet Med 2008;25:570-7. (Pubitemid 351590890)
10. Abell TL, Bernstein RK, Cutts T et al. Treatment of gastroparesis: a multidisciplinary clinical review. Neurogastroenterol Motil 2006;18:263-83.
11. Cassilly DW, Wang YR, Friedenberg FK et al. Symptoms of gastroparesis: use of the gastroparesis cardinal symptom index in symptomatic patients referred for gastric emptying scintigraphy. Digestion 2008;78:144-51.
12. Tack J, Demedts I, Dehondt G et al. Clinical and pathophysiological characteristics of acute-onset functional dyspepsia. Gastroenterology 2002;122:1738-47. (Pubitemid 34651416)
13. Bisschops R, Karamanolis G, Arts J et al. Relationship between symptoms and ingestion of a meal in functional dyspepsia. Gut 2008;57:1495-503.
14. Cherian D, Sachdeva P, Fisher RS et al. Abdominal pain is a frequent symptom of gastroparesis. Clin Gastroenterol Hepatol 2010;8:676-81.
15. Hoogerwerf WA, Pasricha PA, Kalloo AN et al. Pain: the overlooked symptom in gastroparesis. Am J Gastroenterol 1999;94:1029-33. (Pubitemid 29173623)
16. Stanghellini V, Tosetti C, Paternico A et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology 1996;110:1036-42. (Pubitemid 26113742)
17. Sarnelli G, Caenepeel P, Geypens B et al. Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am J Gastroenterol 2003;98:783-8. (Pubitemid 36576302)
18. Maes BD, Ghoos YF, Hiele MI et al. Gastric emptying rate of solids in patients with nonulcer dyspepsia. Dig Dis Sci 1997;42:1158-62. (Pubitemid 27343439)
19. Fischler B, Vandenberghe J, Persoons P et al. Evidence-based subtypes in functional dyspepsia with confirmatory factory analysis: psychosocial and physiopathological correlates. Gastroenterology 2001;120:268-76.
20. Van Oudenhove L, Holvoet L, Vandenberghe J et al. Do we have an alternative for the Rome III gastroduodenal symptom-based subgroups in functional gastroduodenal disorders? A cluster analysis approach. Neurogastroenterol Motil 2011;23:730-8.
21. Holtmann G, Siffert W, Haag S et al. G-protein beta 3 subunit 825 CC genotype is associated with unexplained functional dyspepsia. Gastroenterology 2004;126:971-9. (Pubitemid 38451168)
22. Mearin F, Perez-Oliveras M, Perelio A et al. Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study. Gastroenterology 2005;129:98-104. (Pubitemid 41002046)
23. Thumshirn M, Camilleri M, Saslow SB et al. Gastric accommodation in non-ulcer dyspepsia and the roles of Helicobacter pylori infection and vagal function. Gut 1999;44:55-64. (Pubitemid 29143280)
24. Mimidis K, Tack J. Pathogenesis of dyspepsia. Dig Dis 2008;26:194-202. (Pubitemid 351667801)
25. Lacy BE, Cash BD. A 32-year-old woman with chronic abdominal pain. JAMA 2008;299:555-65. (Pubitemid 351214253)
26. Talley NJ, Walker MM, Aro P et al. Non-ulcer dyspepsia and duodenal eosinophilia: an adult endoscopic population-based case-control study. Clin Gastroenterol Hepatol 2007;5:1175-83. (Pubitemid 47488962)
27. Talley NJ, Choung RS. Whither dyspepsia? A historical perspective of functional dyspepsia, and concepts of pathogenesis and therapy in 2009. Gastroenterol Hepatol 2009;24(Suppl 3):S20-8.
28. Talley NJ, Vakil NB, Moayyedi P. American Gastroenterological Association technical review on the evaluation of dyspepsia. Gastroenterology 2005;129:1756-80. (Pubitemid 41597412)
29. Talley NJ, Vakil N. The Practice Parameters Committee of the American College of Gastroenterology. Guidelines for the management of dyspepsia. Am J Gastroenterol 2005;100:2324-37.
30. Meineche-Schmidt V, Jorgensen T. 'Alarm symptoms' in patients with dyspepsia: a three-year prospective study from general practice. Scand J Gastroenterol 2002;37:999-1007.
31. Vakil N, Moayyedi P, Fennerty MB et al. Limited value of alarm features in the diagnosis of upper gastrointestinal malignancy: systematic review and metaanalysis. Gastroenterology 2006;131:390-401. (Pubitemid 44142444)
32. Hammer J, Eslick GD, Howell SC et al. Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia. Gut 2004;53:666-72. (Pubitemid 38561444)
33. Talley NJ, Haque M, Wyeth JW et al. Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index. Aliment Pharmacol Ther 1998;12:1067-78.
34. Revicki DA, Rentz AM, Dubois D et al. Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms. Qual Life Res 2004;13:833-44. (Pubitemid 38509983)
35. Moayyedi P, Talley NJ, Fennerty MB et al. Can the clinical history distinguish between organic and functional dyspepsia? JAMA 2006;295:1566-76.
36. Priebe WM, DaCosta LR, Beck IT. Is epigastric tenderness a sign of peptic ulcer disease? Gastroenterology 1982;82:16-19. (Pubitemid 12183296)
37. Thomson AB, Barkun AN, Armstrong D et al. The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment-Prompt Endoscopy (CADET-PE) study. Aliment Pharmacol Ther 2003;17:1481-91. (Pubitemid 36831439)
38. Chey WD, Moayyedi P. Uninvestigated dyspepsia and non-ulcer dyspepsia: the use of endoscopy and the roles of Helicobacter pylori eradication and antisecretory therapy. Aliment Pharmacol Ther 2004;19(Suppl 1):1-8. (Pubitemid 38253485)
39. Abell TL, Camilleri M, Donohoe K et al. Consensus recommendations for gastric emptying scintigraphy. A joint report of the Society of Nuclear Medicine and the American Neurogastroenterology and Motility Society. Am J Gastroenterol 2008;103:753-63. (Pubitemid 351405987)
40. Talley NJ, Verlinden M, Snape W et al. Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized, double-blind placebo-controlled trial. Aliment Pharmacol Ther 2000;14:1653-61. (Pubitemid 32011739)
41. Sugumar A, Singh A, Pasricha PJ. A systematic review of the efficacy of domperidone for the treatment of diabetic gastroparesis. Clin Gastroenterol Hepatol 2008;6:726-33.
42. Lacy BE, Talley NJ, Locke GR III et al. Review article: current treatment options and management of functional dyspepsia. Aliment Pharmacol Ther 2012;36:3-15.
43. Chandrasekharan B, Srinivasan S. Diabetes and the enteric nervous system. Neurogastroenterol Motil 2007;19:951-60. (Pubitemid 350198313)
44. Parkman HP, Yates K, Hasler WL et al. Similarities and differences between diabetic and idiopathic gastroparesis. Clin Gastroenterol Hepatol 2011;9:1056-64.
45. Talley NJ, Verlinden M, Geenen DJ et al. Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial. Gut 2001;49:395-401. (Pubitemid 32802575)
46. Talley NJ, Locke GR III, Lahr BD et al. Functional dyspepsia, delayed gastric emptying, and impaired quality of life. Gut 2006;55:933-9. (Pubitemid 43962602)